Arkolith/Insider Trading/QNRX/Form 4/A

Carter Denise P.

Chief Operating Officer, DirectorQuoin Pharmaceuticals, Ltd. (QNRX) · full profile →Form 4/A · filed Jun 13, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 29, 2025Grant(A)43K—$043K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001104659-25-059530) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML